| Amoxicillin/clavulanate (Augmentin), 875 mg/125 mg twice daily* | 10 to 14 days | May use during pregnancy; has coverage for Enterococcus but not useful as empiric treatment for other organisms because of resistance patterns |
| Cefixime (Suprax), 400 mg once daily* | 10 to 14 days | May use during pregnancy, limited evidence for use |
| Cefpodoxime, 200 mg twice daily* | 10 to 14 days | May use during pregnancy, limited evidence for use |
| Cephalexin (Keflex), 500 mg twice daily* | 10 to 14 days | May use during pregnancy, increased resistance risk |
| Ciprofloxacin, 500 mg twice daily† | 7 days | No known risk of teratogenicity based on human and animal data |
| Ciprofloxacin extended release, 1,000 mg once daily† | 7 days | No known risk of teratogenicity based on human and animal data |
| Levofloxacin (Levaquin), 750 mg once daily† | 5 days | No known risk of teratogenicity based on human and animal data |
| Trimethoprim/sulfamethoxazole, 160 mg/800 mg twice daily‡ | 14 days | Avoid use during pregnancy |
